Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Bapcor (BAP.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-03-306.558.10Buy
2022-05-046.257.90Buy
2022-07-286.557.60Buy
2022-08-176.857.70Buy
2022-11-236.737.60Buy
2023-02-176.337.50Buy
2023-06-216.047.20Buy
2023-08-176.597.20Neutral
2024-01-295.586.10Neutral
2024-02-235.996.00Neutral
2024-05-024.404.70Neutral
2024-06-125.02-No Rating

Disclosures

  • UBS Securities Australia Limited is acting as financial advisor to Bain Capital on its acquisition of Bapcor and will receive a fee for acting in this capacity.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.